位置:首页 > 蛋白库 > LNX1_MOUSE
LNX1_MOUSE
ID   LNX1_MOUSE              Reviewed;         728 AA.
AC   O70263; O70264; Q8BRI8; Q8CFR3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   03-AUG-2022, entry version 178.
DE   RecName: Full=E3 ubiquitin-protein ligase LNX;
DE            EC=2.3.2.27;
DE   AltName: Full=Ligand of Numb protein X 1;
DE   AltName: Full=Ligand of Numb-binding protein 1;
DE   AltName: Full=Numb-binding protein 1;
DE   AltName: Full=RING-type E3 ubiquitin transferase LNX {ECO:0000305};
GN   Name=Lnx1; Synonyms=Lnx;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF PRO-181; GLY-182; LEU-183; ASP-184;
RP   ASN-185; PRO-186 AND TYR-188.
RC   TISSUE=Brain, and Embryo;
RX   PubMed=9535908; DOI=10.1074/jbc.273.15.9179;
RA   Dho S.E., Jacob S., Wolting C.D., French M.B., Rohrschneider L.R.,
RA   McGlade C.J.;
RT   "The mammalian numb phosphotyrosine-binding domain. Characterization of
RT   binding specificity and identification of a novel PDZ domain-containing
RT   numb binding protein, LNX.";
RL   J. Biol. Chem. 273:9179-9187(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Brain cortex;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, DOMAIN NPXY MOTIF, AND MUTAGENESIS OF CYS-48.
RX   PubMed=11782429; DOI=10.1093/emboj/21.1.93;
RA   Nie J., McGill M.A., Dermer M., Dho S.E., Wolting C.D., McGlade C.J.;
RT   "LNX functions as a RING type E3 ubiquitin ligase that targets the cell
RT   fate determinant Numb for ubiquitin-dependent degradation.";
RL   EMBO J. 21:93-102(2002).
RN   [5]
RP   FUNCTION, DOMAINS PDZ, AND INTERACTION WITH NUMB.
RX   PubMed=14990566; DOI=10.1074/jbc.m311396200;
RA   Nie J., Li S.S.-C., McGlade C.J.;
RT   "A novel PTB-PDZ domain interaction mediates isoform-specific
RT   ubiquitylation of mammalian Numb.";
RL   J. Biol. Chem. 279:20807-20815(2004).
RN   [6]
RP   INTERACTION WITH IGSF5.
RX   PubMed=16832352; DOI=10.1038/sj.onc.1209468;
RA   Kansaku A., Hirabayashi S., Mori H., Fujiwara N., Kawata A., Ikeda M.,
RA   Rokukawa C., Kurihara H., Hata Y.;
RT   "Ligand-of-Numb protein X is an endocytic scaffold for junctional adhesion
RT   molecule 4.";
RL   Oncogene 25:5071-5084(2006).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination and
CC       subsequent proteasomal degradation of NUMB. E3 ubiquitin ligases accept
CC       ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a
CC       thioester and then directly transfers the ubiquitin to targeted
CC       substrates. Mediates ubiquitination of isoform p66 and isoform p72 of
CC       NUMB, but not that of isoform p71 or isoform p65.
CC       {ECO:0000269|PubMed:11782429, ECO:0000269|PubMed:14990566,
CC       ECO:0000269|PubMed:9535908}.
CC   -!- FUNCTION: Isoform 2 provides an endocytic scaffold for IGSF5/JAM4.
CC       {ECO:0000269|PubMed:9535908}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CXADR. Interacts with MAGEB18 and MAGEF1 (By
CC       similarity). Interacts with the phosphotyrosine interaction domain of
CC       all isoforms of NUMB. IGSF5/JAM4 interacts with isoform 2 through the
CC       second PDZ domain, other isoforms may also interact with IGSF5/JAM4.
CC       {ECO:0000250, ECO:0000269|PubMed:14990566,
CC       ECO:0000269|PubMed:16832352}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=LNX, LNXp80;
CC         IsoId=O70263-1; Sequence=Displayed;
CC       Name=2; Synonyms=LNX-B, LNXp70;
CC         IsoId=O70263-2; Sequence=VSP_005734;
CC       Name=3;
CC         IsoId=O70263-3; Sequence=VSP_005734, VSP_012588, VSP_012589;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in the heart.
CC       Isoform 1 is also expressed in kidney, lung and skeletal muscle while
CC       isoform 2 is also expressed in brain. {ECO:0000269|PubMed:9535908}.
CC   -!- DOMAIN: The NPXY motif is required for the interaction with the PID
CC       domain of NUMB. It is however not sufficient.
CC   -!- DOMAIN: The PDZ 1 domain participates in the interaction with the PID
CC       domain of NUMB, and participates in the isoform-specific ubiquitination
CC       of NUMB. The PDZ 2 domain of isoform 2 participates in the interaction
CC       with IGSF5/JAM4, other isoforms containing this domain may also
CC       interact with IGSF5/JAM4.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF034745; AAC40075.1; -; mRNA.
DR   EMBL; AF034746; AAC40076.1; -; mRNA.
DR   EMBL; AK044127; BAC31789.1; -; mRNA.
DR   EMBL; BC040367; AAH40367.1; -; mRNA.
DR   CCDS; CCDS19347.1; -. [O70263-2]
DR   CCDS; CCDS51524.1; -. [O70263-1]
DR   PIR; T09457; T09457.
DR   PIR; T09458; T09458.
DR   RefSeq; NP_001153049.1; NM_001159577.1. [O70263-1]
DR   RefSeq; NP_001153050.1; NM_001159578.1.
DR   RefSeq; NP_001153051.1; NM_001159579.1. [O70263-2]
DR   RefSeq; NP_001153052.1; NM_001159580.1.
DR   RefSeq; NP_034857.3; NM_010727.4. [O70263-2]
DR   RefSeq; XP_006504317.1; XM_006504254.3. [O70263-1]
DR   PDB; 3VQF; X-ray; 1.20 A; A=381-467.
DR   PDB; 3VQG; X-ray; 1.35 A; A=381-467.
DR   PDBsum; 3VQF; -.
DR   PDBsum; 3VQG; -.
DR   AlphaFoldDB; O70263; -.
DR   SMR; O70263; -.
DR   BioGRID; 201187; 87.
DR   CORUM; O70263; -.
DR   IntAct; O70263; 3.
DR   MINT; O70263; -.
DR   STRING; 10090.ENSMUSP00000113035; -.
DR   iPTMnet; O70263; -.
DR   PhosphoSitePlus; O70263; -.
DR   PaxDb; O70263; -.
DR   PRIDE; O70263; -.
DR   ProteomicsDB; 290136; -. [O70263-1]
DR   ProteomicsDB; 290137; -. [O70263-2]
DR   ProteomicsDB; 290138; -. [O70263-3]
DR   Antibodypedia; 1114; 237 antibodies from 29 providers.
DR   DNASU; 16924; -.
DR   Ensembl; ENSMUST00000039744; ENSMUSP00000040098; ENSMUSG00000029228. [O70263-2]
DR   Ensembl; ENSMUST00000087161; ENSMUSP00000084405; ENSMUSG00000029228. [O70263-1]
DR   Ensembl; ENSMUST00000117388; ENSMUSP00000113035; ENSMUSG00000029228. [O70263-1]
DR   Ensembl; ENSMUST00000117525; ENSMUSP00000113837; ENSMUSG00000029228. [O70263-2]
DR   GeneID; 16924; -.
DR   KEGG; mmu:16924; -.
DR   UCSC; uc008xtr.2; mouse. [O70263-1]
DR   UCSC; uc008xtu.2; mouse. [O70263-3]
DR   CTD; 84708; -.
DR   MGI; MGI:1278335; Lnx1.
DR   VEuPathDB; HostDB:ENSMUSG00000029228; -.
DR   eggNOG; KOG0297; Eukaryota.
DR   eggNOG; KOG3528; Eukaryota.
DR   GeneTree; ENSGT00940000158757; -.
DR   HOGENOM; CLU_021213_0_0_1; -.
DR   InParanoid; O70263; -.
DR   OMA; AYGPRDD; -.
DR   OrthoDB; 615205at2759; -.
DR   PhylomeDB; O70263; -.
DR   TreeFam; TF330709; -.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 16924; 2 hits in 73 CRISPR screens.
DR   ChiTaRS; Lnx1; mouse.
DR   PRO; PR:O70263; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; O70263; protein.
DR   Bgee; ENSMUSG00000029228; Expressed in motor neuron and 225 other tissues.
DR   ExpressionAtlas; O70263; baseline and differential.
DR   Genevisible; O70263; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:MGI.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:MGI.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:MGI.
DR   Gene3D; 2.30.42.10; -; 4.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00595; PDZ; 4.
DR   SMART; SM00228; PDZ; 4.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF50156; SSF50156; 4.
DR   PROSITE; PS50106; PDZ; 4.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Transferase;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..728
FT                   /note="E3 ubiquitin-protein ligase LNX"
FT                   /id="PRO_0000055914"
FT   DOMAIN          278..362
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          385..467
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          508..593
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          638..723
FT                   /note="PDZ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   ZN_FING         45..83
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          185..220
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          186..244
FT                   /note="Interaction with MAGEB18"
FT                   /evidence="ECO:0000250"
FT   REGION          481..500
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           185..188
FT                   /note="NPXY motif"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TBB1"
FT   VAR_SEQ         1..131
FT                   /note="MNQPDLADDPDPSPEPLCIVCGQNHSPEENHFYTYTEDVDDDLICHICLQAL
FT                   LDPLDTPCGHTYCTLCLTNFLVEKDFCPVDRKPVVLQHCKKSSILVNKLLNKLLVTCPF
FT                   TEHCTEVLQRCDLQHHFQTS -> MKALLLLVLPWLSPANYIDNVGNLHFLYSEL (in
FT                   isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072, ECO:0000303|PubMed:9535908"
FT                   /id="VSP_005734"
FT   VAR_SEQ         332..357
FT                   /note="NGMDISNVPHNYAVRLLRQPCQVLRL -> PMRRELVTIGYKIVSCRLCVAH
FT                   NLSP (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012588"
FT   VAR_SEQ         358..728
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012589"
FT   MUTAGEN         48
FT                   /note="C->A: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11782429"
FT   MUTAGEN         181
FT                   /note="P->A: No effect on binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         182
FT                   /note="G->A: Slightly affects binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         183
FT                   /note="L->A: Abolishes binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         184
FT                   /note="D->A: Slightly affects binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         185
FT                   /note="N->A: Abolishes binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         186
FT                   /note="P->A: Slightly affects binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         188
FT                   /note="Y->A: Abolishes binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   MUTAGEN         188
FT                   /note="Y->F: No effect on binding to NUMB protein."
FT                   /evidence="ECO:0000269|PubMed:9535908"
FT   CONFLICT        258
FT                   /note="T -> N (in Ref. 2; BAC31789)"
FT                   /evidence="ECO:0000305"
FT   STRAND          384..389
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   STRAND          398..402
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   STRAND          405..407
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   STRAND          409..415
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   HELIX           420..424
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   STRAND          432..436
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   HELIX           446..455
FT                   /evidence="ECO:0007829|PDB:3VQF"
FT   STRAND          456..465
FT                   /evidence="ECO:0007829|PDB:3VQF"
SQ   SEQUENCE   728 AA;  80157 MW;  E2914BD364C0CEC4 CRC64;
     MNQPDLADDP DPSPEPLCIV CGQNHSPEEN HFYTYTEDVD DDLICHICLQ ALLDPLDTPC
     GHTYCTLCLT NFLVEKDFCP VDRKPVVLQH CKKSSILVNK LLNKLLVTCP FTEHCTEVLQ
     RCDLQHHFQT SCKGASHYGL TKDRKRRSQD GCPDGCASLM ATTLSPEVSA AATISLMTDE
     PGLDNPAYVS SVEDGEPVAN SSDSGRSNRT RARPFERSTM RSRSFKKINR ALSALRRTKS
     GSVVANHVDQ GRDNSENTTV PEVFPRLFHL IPDGEITSIK INRADPSESL SIRLVGGSET
     PLVHIIIQHI YRDGVIARDG RLLPGDIILK VNGMDISNVP HNYAVRLLRQ PCQVLRLTVL
     REQKFRSRSN AHVPDSYGPR DDSFHVILNK SSPEEQLGIK LVRRVDEPGV FIFNVLNGGV
     ADRHGQLEEN DRVLAINGHD LRFGSPESAA HLIQASERRV HLVVSRQVRQ SSPDIFQEAG
     WISNGQQSPG PGERNTASKP AATCHEKVVS VWKDPSESLG MTVGGGASHR EWDLPIYVIS
     VEPGGVISRD GRIKTGDILL NVNGIELTEV SRTEAVAILK SAPSSVVLKA LEVKEQEAQE
     DCSPAALDSN HNVTPPGDWS PSWVMWLELP QYLCNCKDVI LRRNTAGSLG FCIVGGYEEY
     SGNKPFFIKS IVEGTPAYND GRIRCGDILL AVNGRSTSGM IHACLARMLK ELKGRITLTI
     ASWPGTFL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024